A novel mechanism is through the targeting of chromatin-modifying enzymes such as euchromatic histone-lysine N-methyltransferase 2 (EHMT2) or G9a, a histone H3K9 methyltransferase overexpressed in NPC [84]. Here, EHMT2 is linked to nasopharyngeal carcinoma.